Scott Henry
Stock Analyst at Alliance Global Partners
(1.24)
# 3,767
Out of 5,113 analysts
60
Total ratings
37.74%
Success rate
-5.54%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.93 | +222.48% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.20 | +212.50% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $1.71 | +250.88% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $9.46 | +5.71% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $41 | $11.81 | +249.28% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $8.33 | +2.04% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.90 | +344.00% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $3.38 | +343.79% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.29 | +3,995.56% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $7.62 | -1.57% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.92 | +31.05% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $30.41 | -21.08% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $190.22 | -52.69% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $24.20 | -35.95% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $85.06 | -31.81% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $97.92 | -63.24% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.48 | +643.24% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $5.11 | +17.42% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $1.07 | +537,283.18% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.51 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.86 | +711.31% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.29 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.00 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.93
Upside: +222.48%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.20
Upside: +212.50%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $1.71
Upside: +250.88%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $9.46
Upside: +5.71%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $41
Current: $11.81
Upside: +249.28%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $8.33
Upside: +2.04%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.90
Upside: +344.00%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $3.38
Upside: +343.79%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.29
Upside: +3,995.56%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $7.62
Upside: -1.57%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.92
Upside: +31.05%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $30.41
Upside: -21.08%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $190.22
Upside: -52.69%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $24.20
Upside: -35.95%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $85.06
Upside: -31.81%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $97.92
Upside: -63.24%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.48
Upside: +643.24%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $5.11
Upside: +17.42%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $1.07
Upside: +537,283.18%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.51
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.86
Upside: +711.31%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $18.29
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.00
Upside: -